Thomas Chen
Director/Miembro de la Junta en Cognos Therapeutics, Inc. .
Perfil
Thomas Chen is currently working as the Director, Chief Neuro-Surgeon & Oncology Officer at Cognos Therapeutics, Inc. and Cognos Therapeutics Holdings, Inc. He completed his undergraduate degree in 1995 and doctorate in 1996 from the University of Southern California.
He also completed his doctorate from The University of California, San Francisco in 1988 and his undergraduate degree from the University of Illinois.
Cargos activos de Thomas Chen
| Empresas | Cargo | Inicio |
|---|---|---|
Cognos Therapeutics, Inc.
 Cognos Therapeutics, Inc. BiotechnologyHealth Technology Cognos Therapeutics, Inc. operates as a medical device company focusing on creating technologies to diagnosis and treatment of neuropathic diseases. Its treatment of diseases including tumor-based brain and spinal cancers, degenerative cognition disorders (such as Alzheimer?s and Parkinson?s disease), cerebral trauma occurrences (such as epilepsy and stroke) as well as other central nervous system afflictions. The company is headquartered in Los Angeles, CA. | Director/Miembro de la Junta | - |
Formación de Thomas Chen.
| The University of California, San Francisco | Doctorate Degree |
| University of Southern California | Undergraduate Degree |
| University of Illinois | Undergraduate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas privadas | 1 |
|---|---|
Cognos Therapeutics, Inc.
Cognos Therapeutics, Inc. BiotechnologyHealth Technology Cognos Therapeutics, Inc. operates as a medical device company focusing on creating technologies to diagnosis and treatment of neuropathic diseases. Its treatment of diseases including tumor-based brain and spinal cancers, degenerative cognition disorders (such as Alzheimer?s and Parkinson?s disease), cerebral trauma occurrences (such as epilepsy and stroke) as well as other central nervous system afflictions. The company is headquartered in Los Angeles, CA. | Health Technology |
- Bolsa de valores
- Insiders
- Thomas Chen
